# enGene Therapeutics Inc.: Form 8-K, filed Dec 22, 2025

- Company: [enGene Therapeutics Inc.](/companies/engn.md) (CIK 1980845)
- Form: 8-K
- Filed: 2025-12-22
- Accepted by EDGAR: Dec 22, 2025, 16:04 ET
- Period: 2025-12-22
- Accession: 0001193125-25-328706
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1980845/000119312525328706/engn-20251222.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1980845/000119312525328706/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1980845/000119312525328706/engn-20251222.htm

Filed Dec 22, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-328706. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.